Gilad Oren - Insider Non-Derivative Transactions at Aprea Therapeutics, Inc. (APRE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 28, 2024, Gilad Oren's relationship to Aprea Therapeutics, Inc. (APRE) is Director,Officer (President, CEO), and currently has 331,495 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other APRE insiders.
Data Source: SEC.
Gilad Oren - Insider Non-Derivative Transactions of APRE Common Stock
Gilad Oren - Insider Non-Derivative Transactions at APRE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 29, 2024 | Acquisition -- (Common Stock) | 6725 | 0 | 331495 |
| Mar 14, 2024 | P -- (Common Stock) | 2000 | 7.29 | 324770 |
| Mar 10, 2023 | Acquisition -- (Common Stock) | 4000 | 0 | 322770 |
| Aug 24, 2022 | C -- (Common Stock) | 6045100 | 0 | 6375414 |